Since pyroptosis is classically activated through the NLRP3/caspase 1/GSDMD axis, several studies have investigated the efficacy of specific inhibitors targeting this axis to mitigate pyroptotic death in IHD. The gene discussed is GSDMD; the disease is myocardial ischemia.